DiagnaMed Announces $510,000 Private Placement to Boost Hydrogen and AI Initiatives

Story Highlights
  • DiagnaMed is offering up to $510,000 in a private placement to fund its hydrogen and AI projects.
  • The offering includes units with shares and warrants, closing by March 31, 2025, pending approvals.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
DiagnaMed Announces $510,000 Private Placement to Boost Hydrogen and AI Initiatives

An announcement from DiagnaMed Holdings Corp. ( (TSE:DMED) ) is now available.

DiagnaMed Holdings Corp. has announced a private placement offering of up to $510,000, led by EMD Financial Inc., to support its research, development, and commercialization efforts in hydrogen production and its BRAIN AGE® Brain Health AI Platform. The offering will consist of units priced at $0.03 each, with each unit including one common share and one warrant, allowing the purchase of an additional share at $0.05 within 24 months. The funds raised will also be used for general corporate purposes, with the offering expected to close by March 31, 2025, pending necessary approvals.

More about DiagnaMed Holdings Corp.

DiagnaMed Holdings Corp. is a company that provides innovative technology solutions for the cleantech and life sciences industries, focusing on hydrogen production and AI-driven drug discovery and diagnostics.

YTD Price Performance: -37.50%

Average Trading Volume: 194,654

Technical Sentiment Consensus Rating: Buy

For a thorough assessment of DMED stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App